BioCentury | Sep 24, 2020
Emerging Company Profile

Libra launches with $29M, three neurodegeneration programs to lower toxic protein levels

...a $29 million series A co-led by Boehringer Ingelheim Venture Fund, Epidarex...
...partners: AxxamNumber of employees: 1Funds raised: $29 millionInvestors: Boehringer Ingelheim Venture Fund, Epidarex...
BioCentury | Aug 14, 2020
Finance

Aug. 13 Quick Takes: Qiagen shareholders opt for independence; plus IPO terms from Inhibrx, Harmony and more from Biohaven-Royalty, Scioto, Bodyport, immunoSCAPE

...and develop biomarkers for the early detection of cardiovascular disease. The round was led by Boehringer Ingelheim Venture Fund...
BioCentury | Aug 6, 2020
Emerging Company Profile

T-knife: creating TCR factories with transgenic mice

...Medicine in 2018 with €8 million in seed funding from founding investors Andera Partners and Boehringer Ingelheim Venture Fund...
...of employees: 18 Funds raised: €74 million Investors: Versant Ventures, RA Capital Management, Andera Partners, Boehringer Ingelheim Venture Fund...
BioCentury | Jul 6, 2020
Product Development

July 6 Quick Takes: Cellectis CAR T trial halted; plus data readouts from Bellus, ObsEva, Idorsia, and more

...three of the pharma’s programs -- Research Beyond Borders, Business Development & Licensing and the Boehringer Ingelheim Venture Fund...
BioCentury | Jun 18, 2020
Finance

June 17 Quick Takes: Constellation, Celldex raise follow-ons; plus CureVac quiet on IPO chatter and venture cash for GreenLight, TILT, DiogenX

...raises €4.5M Type I diabetes company DiogenX has raised €4.5 million from Advent France Biotechnology, Boehringer Ingelheim Venture Fund...
BioCentury | Jun 16, 2020
Finance

eTheRNA’s €34M series B to support different take on COVID-19 vaccine, build out core cancer pipeline

...Ltd. (HKEX:512); Yijing Capital; BNP Paribas Fortis Private Equity; and Novalis LifeSciences LLC. Existing investors Boehringer Ingelheim Venture Fund...
BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...immunotherapies Immuno-oncology play Actym Therapeutics Inc. raised $34 million in a series A led by Boehringer Ingelheim Venture Fund...
BioCentury | Apr 17, 2020
Emerging Company Profile

Rgenta: enhancing interactions between RNA and RNA-binding proteins

...Massachusetts Medical School Corporate partners: N/A Number of employees: 6 Funds raised: $20 million Investors: Boehringer Ingelheim Venture Fund...
BioCentury | Apr 3, 2020
Product Development

April 2 Quick Takes: Horizon takes out Curzion; plus Rgenta, Merck, Novartis-Aurobindo, Kite, Teneobio and Seattle Genetics

...Rgenta in $20M seed round Rgenta Therapeutics announced a $20 million seed round led by Boehringer Ingelheim Venture Fund...
BioCentury | Feb 22, 2020
Product Development

Regenerative medicine for hearing loss makes quiet progress

...Rinri Therapeutics Ltd., which received a £1.4 million ($1.8 million) seed round last May from Boehringer Ingelheim Venture Fund...
Items per page:
1 - 10 of 104
BioCentury | Sep 24, 2020
Emerging Company Profile

Libra launches with $29M, three neurodegeneration programs to lower toxic protein levels

...a $29 million series A co-led by Boehringer Ingelheim Venture Fund, Epidarex...
...partners: AxxamNumber of employees: 1Funds raised: $29 millionInvestors: Boehringer Ingelheim Venture Fund, Epidarex...
BioCentury | Aug 14, 2020
Finance

Aug. 13 Quick Takes: Qiagen shareholders opt for independence; plus IPO terms from Inhibrx, Harmony and more from Biohaven-Royalty, Scioto, Bodyport, immunoSCAPE

...and develop biomarkers for the early detection of cardiovascular disease. The round was led by Boehringer Ingelheim Venture Fund...
BioCentury | Aug 6, 2020
Emerging Company Profile

T-knife: creating TCR factories with transgenic mice

...Medicine in 2018 with €8 million in seed funding from founding investors Andera Partners and Boehringer Ingelheim Venture Fund...
...of employees: 18 Funds raised: €74 million Investors: Versant Ventures, RA Capital Management, Andera Partners, Boehringer Ingelheim Venture Fund...
BioCentury | Jul 6, 2020
Product Development

July 6 Quick Takes: Cellectis CAR T trial halted; plus data readouts from Bellus, ObsEva, Idorsia, and more

...three of the pharma’s programs -- Research Beyond Borders, Business Development & Licensing and the Boehringer Ingelheim Venture Fund...
BioCentury | Jun 18, 2020
Finance

June 17 Quick Takes: Constellation, Celldex raise follow-ons; plus CureVac quiet on IPO chatter and venture cash for GreenLight, TILT, DiogenX

...raises €4.5M Type I diabetes company DiogenX has raised €4.5 million from Advent France Biotechnology, Boehringer Ingelheim Venture Fund...
BioCentury | Jun 16, 2020
Finance

eTheRNA’s €34M series B to support different take on COVID-19 vaccine, build out core cancer pipeline

...Ltd. (HKEX:512); Yijing Capital; BNP Paribas Fortis Private Equity; and Novalis LifeSciences LLC. Existing investors Boehringer Ingelheim Venture Fund...
BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...immunotherapies Immuno-oncology play Actym Therapeutics Inc. raised $34 million in a series A led by Boehringer Ingelheim Venture Fund...
BioCentury | Apr 17, 2020
Emerging Company Profile

Rgenta: enhancing interactions between RNA and RNA-binding proteins

...Massachusetts Medical School Corporate partners: N/A Number of employees: 6 Funds raised: $20 million Investors: Boehringer Ingelheim Venture Fund...
BioCentury | Apr 3, 2020
Product Development

April 2 Quick Takes: Horizon takes out Curzion; plus Rgenta, Merck, Novartis-Aurobindo, Kite, Teneobio and Seattle Genetics

...Rgenta in $20M seed round Rgenta Therapeutics announced a $20 million seed round led by Boehringer Ingelheim Venture Fund...
BioCentury | Feb 22, 2020
Product Development

Regenerative medicine for hearing loss makes quiet progress

...Rinri Therapeutics Ltd., which received a £1.4 million ($1.8 million) seed round last May from Boehringer Ingelheim Venture Fund...
Items per page:
1 - 10 of 104